Skip to main content

Advertisement

SpringerLink
Log in

Encapsulated Malignant Follicular Cell-Derived Thyroid Tumors

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Encapsulated malignant follicular cell-derived thyroid tumors are subject to considerable controversies. This group includes encapsulated follicular variant of papillary carcinoma (FVPTC) and encapsulated (so-called minimally invasive) follicular carcinoma (EFC). FVPTC usually presents as an encapsulated tumor and less commonly as a partially/nonencapsulated infiltrative neoplasm. The encapsulated form rarely metastasizes to lymph node, whereas infiltrative tumors often harbor nodal metastases. Encapsulated FVPTC have a molecular profile very close to follicular adenomas/carcinomas (high rate of RAS and absence of BRAF mutations). Infiltrative follicular variant has an opposite molecular profile closer to classical papillary thyroid carcinoma than to follicular adenoma/carcinoma (BRAF > RAS mutations). Noninvasive encapsulated FVPTC are extremely indolent even if treated with lobectomy without radioactive iodine therapy. Although most EFC are thought to have an excellent outcome, there are cases of EFC that recur and metastasize. EFC with angioinvasion, especially if extensive, have a significant rate of distant recurrence. Encapsulated FVPTC have a molecular profile and a clinical behavior very similar to the follicular adenoma/carcinoma class of tumor. If noninvasive, encapsulated FVPTC should be treated in a very conservative fashion. EFC with angioinvasion, especially if extensive, should not be termed minimally invasive in order to prevent undertreatment of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Passler C, Prager G, Scheuba C, et al: Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch Surg 138:1362–6, 2003

    Article  PubMed  Google Scholar 

  2. Carcangiu ML, Zampi G, Pupi A, et al: Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805–28, 1985

    Article  CAS  PubMed  Google Scholar 

  3. Tielens ET, Sherman SI, Hruban RH, et al: Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73:424–31, 1994

    Article  CAS  PubMed  Google Scholar 

  4. Sebastian SO, Gonzalez JM, Paricio PP, et al: Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 135:272–7, 2000

    Article  CAS  PubMed  Google Scholar 

  5. Rosai J, Carcangiu ML, Delellis RA: Tumors of the thyroid gland, atlas of tumor pathology. Washington, Armed Forces Institute of Pathology, 1992, pp 161–182.

    Google Scholar 

  6. Chan JK: Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 117:16–8, 2002

    Article  PubMed  Google Scholar 

  7. Lloyd RV, Erickson LA, Casey MB, et al: Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28:1336–40, 2004

    Article  PubMed  Google Scholar 

  8. Solomon BL, Wartofsky L, Burman KD: Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 81:333–9, 1996

    Article  CAS  PubMed  Google Scholar 

  9. Baloch ZW, LiVolsi VA: Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol 13:861–5, 2000

    Article  CAS  PubMed  Google Scholar 

  10. Zhu Z, Gandhi M, Nikiforova MN, et al: Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of RAS mutations. Am J Clin Pathol 120:71–7, 2003

    Article  CAS  PubMed  Google Scholar 

  11. Jain M, Khan A, Patwardhan N, et al: Follicular variant of papillary thyroid carcinoma: a comparative study of histopathologic features and cytology results in 141 patients. Endocr Pract 7:79–84, 2001

    CAS  PubMed  Google Scholar 

  12. Wreesmann VB, Ghossein RA, Hezel M, et al: Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 40:355–64, 2004

    Article  CAS  PubMed  Google Scholar 

  13. Castro P, Rebocho AP, Soares RJ, et al: PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213–20, 2006

    Article  CAS  PubMed  Google Scholar 

  14. Liu J, Singh B, Tallini G et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255–64, 2006.

    Article  PubMed  Google Scholar 

  15. Chem KT, Rosai J: Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol 1:123–30, 1977

    Article  CAS  PubMed  Google Scholar 

  16. Zidan J, Karen D, Stein M, et al. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer. 97: 1181–1185, 2003.

    Article  PubMed  Google Scholar 

  17. LiVolsi V: Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors. Cancer 98:1997, 2003.

    Article  PubMed  Google Scholar 

  18. Adeniran A, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol 30:216–22, 2006.

    Article  PubMed  Google Scholar 

  19. Trovisco V, Vieira de Castro I, Soares P, et al: BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202:247–51, 2004.

    Article  CAS  PubMed  Google Scholar 

  20. Rivera M, Ricarte-Filho J, Knauf J, Tuttle RM, Fagin J, Ghossein R. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histologic subtypes (encapsulated vs non-encapsulated infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 2010;23:1191–1200

    Article  CAS  PubMed  Google Scholar 

  21. Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 91: 505–524, 2001

    Article  CAS  PubMed  Google Scholar 

  22. Evans HL, Vassilopoulou-Sellin R. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol. 22: 1512–1520, 1998.

    Article  CAS  PubMed  Google Scholar 

  23. Van Heerden JA, Hay ID, GOellner JR et al. Follicular thyroid carcinoma with capsular invasion alone: a non-threatening malignancy Surgery 112:1130–1136, 1992.

    PubMed  Google Scholar 

  24. Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol. 10: 246–255, 1986.

    Article  CAS  PubMed  Google Scholar 

  25. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117:143–50, 2002

    Article  PubMed  Google Scholar 

  26. Stojadinovic A, Ghossein RA, Hoos A, et al. Hurthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol. 19:2616–2625, 2001

    CAS  PubMed  Google Scholar 

  27. Ghossein RA, Hiltzik DH, Carlson DL et al. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer. 106:1669–76, 2006.

    Article  PubMed  Google Scholar 

  28. Collini P, Sampietro G, Pilotti S. Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hurthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with an 11-year median follow-up. Histopathology. 44: 35–39, 2004.

    Article  CAS  PubMed  Google Scholar 

  29. Kahn NF, Perzin KH. Follicular carcinoma of the thyroid: an evaluation of the histologic criteria used for diagnosis. Pathol Annu. 18(Pt 1): 221–253, 1983.

    PubMed  Google Scholar 

  30. Williams ED. Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol. 8:181–183, 2000.

    Article  PubMed  Google Scholar 

  31. Ghossein R. Update to the College of American Pathologists reporting on thyroid carcinomas. Head and Neck Pathol. 3:86–93, 2009.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Ronald Ghossein

Authors
  1. Ronald Ghossein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronald Ghossein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghossein, R. Encapsulated Malignant Follicular Cell-Derived Thyroid Tumors. Endocr Pathol 21, 212–218 (2010). https://doi.org/10.1007/s12022-010-9141-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-010-9141-8

Keywords

Search

Navigation